Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioma 2Glioblastoma 2Unspecified Adult Solid Tumor, Protocol Specific 1Sarcoma 1Neoplasms 1Meningioma 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 4Temozolomide 3Surgical Procedures, Operative 3trametinib 2Magnetic Resonance Imaging 2Irinotecan 2Bortezomib 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2temsirolimus 1sonidegib 1ribociclib 1gallium Ga 68 dotatate 1fluoromisonidazole 1entinostat 1emvododstat 1carboxyamido-triazole 1avelumab 1aldesleukin 1Vorinostat 1Verteporfin 1Topotecan 1Thalidomide 1Surveys and Questionnaires 1Sodium Chloride 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiosurgery 1Proton Therapy 1Pioglitazone 1Photochemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Meningioma × fluoromisonidazole × Clear all
NCT01246869 2024-10-01

Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water

University of Utah

Phase 1 Terminated
2 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡